Used in research settings as a selective antagonist for serotonin receptors, particularly the 5-HT2A subtype, aiding in the study of serotonin signaling pathways and neuropsychiatric disorders. Its application is primarily confined to in vitro and animal models to investigate the role of serotonergic transmission in behavior, cognition, and mood regulation. Due to its specificity, it serves as a pharmacological tool to differentiate receptor subtype functions and assess potential therapeutic targets for psychiatric conditions such as schizophrenia and depression. Not intended for clinical use or human consumption.